AL
OSIR

Airain Ltd’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Airain Ltd’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-12,957
Closed -$228K – 1276
2015
Q1 		$228K Buy
+12,957
New +$218K 0.01% 685

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Airain Ltd's OSIR Position: Q2 2015 in Review

Airain Ltd sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2015, closing a stake of 12,957 shares — an estimated $228K sold.

Airain Ltd first reported a position in OSIR in Q1 2015 and held it in 1 quarter. The position peaked at $228K in Q1 2015. 87 funds tracked by Wall St. Rank hold OSIR as of Q2 2015.

  • Airain Ltd reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • Airain Ltd sold 12,957 Osiris Therapeutics, Inc. Common Stock shares in Q2 2015, an estimated $228K.
  • Airain Ltd first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2015 and held it in 1 quarter.
  • Airain Ltd's Osiris Therapeutics, Inc. Common Stock position peaked at $228K in Q1 2015.
  • 87 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2015.

Based on Airain Ltd's 13F filing for Q2 2015, filed 5 Aug 2015.